Women’s health companies secured a record $1.55bn in funding in 2025, hinting that investors’ faith is growing in this sector. According to a global women’s health investmen ...

Blood-based biomarkers could play a key role in detecting and treating Alzheimer’s early at the first point of contact, experts say.

The US Food and Drug Administration (FDA) has granted priority review to Roche’s supplemental biologics licence application (sBLA) for Gazyva/Gazyvaro (obinutuzumab) to treat ad ...

Innovent Biologics has granted Spero Therapeutics an exclusive licence deal to develop and commercialise IBI355 outside Greater China.

Novartis has entered a collaboration with Chai Discovery to advance the use of AI in the identification of therapeutic antibodies.

Cellares and Sonoma Biotherapeutics have partnered to automate the manufacturing of the latter’s SBT-77-7101 programme using the Cellares Cell Shuttle platform.

Delve into the current compliance landscape for life sciences manufacturers and the vulnerabilities found in legacy quality systems.

There are a range of cost-containment measures across the bill that will create a significant healthcare system shakeup.

Patient advocates in remission from MCL and FL discuss their treatment experiences with ASCT and CAR-T, while sharing views on latter's place in the treatment paradigm.

The proposed rule would allow multiple manufacturing units at different locations to register as one establishment.